John Libbey Eurotext

European Journal of Dermatology


Early and sustained remission with brentuximab vedotin in a case of disseminated cutaneous relapse from systemic anaplastic large cell lymphoma refractory to chemotherapy Volume 27, numéro 6, November-December 2017


  • Figure 1
1 Medical Oncology,
2 Dermatology,
3 Pathology, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria. Las Palmas, Spain

Recurrence of systemic anaplastic large T-cell lymphoma (ALTCL) is considered a sign associated with poor prognosis [1]. Exclusive cutaneous recurrence is a particularly rare event with unknown behaviour due to the paucity of cases reported to date, most of which included short follow-up periods [2]. Several treatment options are available, ranging from local therapies in cases of isolated lesions, to systemic chemotherapy or new monoclonal antibodies in cases of disseminated disease. Brentuximab [...]